Proceeding of EOGM of the company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals held an Extra Ordinary General Meeting (EOGM) on Saturday, November 01, 2025, via video conferencing from 11:30 a.m. to 11:51 a.m. (IST). The meeting was chaired by Managing Director Mr. Dakshesh Shah, with Company Secretary Ms. Arpita Kabra conducting the proceedings. The sole item of special business transacted was the issue of convertible equity warrants on a preferential basis. No shareholders raised any queries during the meeting. The Company had provided remote e-voting facility from October 29 to October 31, 2025, with Mrs. Rupal Patel appointed as Scrutinizer. Voting results are awaited and will be announced within 48 hours of meeting conclusion.
If the preferential warrant issue is approved by shareholders, the company will raise fresh capital, but it may lead to dilution of existing equity holders once the warrants are converted. Investors should watch for the voting outcome announcement within 48 hours for confirmation.